Drug and Gene Delivery

Associate Professor and Undergraduate Program Director

---

Teaching and mentoring students in the areas of physiology, cell and molecular biology and biomedical innovation.

Associate Professor

---

We utilize synthetic biology to address emergent challenges across diverse areas such as advanced biomanufacturing, improving drug bioavailability and combating antimicrobial resistance.

Professor

---

Combining advanced methods of targeted drug and gene delivery with biomedical imaging in vivo to explore novel targets and treatment strategies in cardiovascular disease and cancer.

Professor

---

Developing ultrasound imaging approaches for cardiovascular disease, including mouse heart imaging, catheter-based imaging and drug delivery, and molecular imaging for diagnosing stroke risk.

Professor

---

Developing phage-based nanoparticle techniques for diagnostic imaging, drug target identification, and drug delivery in the setting of pancreatic cancer.

Professor

---

Developing ultrasound-activated drug and gene delivery systems for treating cancer and Parkinson’s disease. Investigating the mechanisms through which collateral arteries grow and adapt in response to changes in blood flow.

Assistant Professor

---

Working at the nexus of therapeutic ultrasound, advanced imaging, and tumor immunology to design and deploy precision cancer immunotherapy paradigms.

Associate Professor of Chemical Engineering

---

Biomaterials for tissue engineering, regenerative medicine, and drug delivery within the central nervous system, developing both synthetic polymers and recombinant engineered proteins.

Associate Professor of Cardiovascular Medicine

---

Pre-clinical research in the field of targeted imaging and drug delivery. Preparing and analyzing ultrasound contrast materials, attach targeting ligands (antibodies, peptides) and plasmid DNA to their surface for targeting and ultrasound-enhanced...

---

The $8 million investment will generate clinical trials and other research that will directly benefit patients.